Back
Acuity Brands 10K Form
Buy
73
AYI
Acuity Brands
Last Price:
308.83
Seasonality Move:
10.41%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-06-27 | 10Q | AYI/Acuity Brands Quarterly |
2024-04-03 | 10Q | AYI/Acuity Brands Quarterly |
2024-01-09 | 10Q | AYI/Acuity Brands Quarterly |
2023-10-26 | 10K | AYI/Acuity Brands Annual |
2023-06-29 | 10Q | AYI/Acuity Brands Quarterly |
2023-04-04 | 10Q | AYI/Acuity Brands Quarterly |
Receive AYI News And Ratings
See the #1 stock for the next 7 days that we like better than AYI
AYI Financial Statistics
Sales & Book Value
Annual Sales: | $3.84B |
---|---|
Cash Flow: | $151.1M |
Price / Cash Flow: | 17.39 |
Annual Sales: | $77.07 |
Price / Book: | 3.98 |
Profitability
EPS (TTM): | 13.44000 |
---|---|
Net Income (TTM): | $422.6M |
Gross Margin: | $1.78B |
Return on Equity: | 19.45% |
Return on Assets: | 11.83% |
Acuity Brands Earnings Forecast
Key Acuity Brands Financial Ratios
- The Gross Profit Margin over the past 24 years for AYI is 46.39%.
- The Selling, General & Administrative Expenses for AYI have been equal to 29.32% of Gross Profit Margin.
- The Research & Development expenses have been 2.66% of Revenue.
- The Interest Expense is 5.99% of Operating Income.
- The Net Earning history of AYI is 11.00% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 16 years.
Acuity Brands Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Electrical Equipment |
Sector: | Industrials |
Current Symbol: | AYI |
CUSIP: | 00508Y |
Website: | acuitybrands.com |
Debt
Debt-to-Equity Ratio: | 0.21 |
---|---|
Current Ratio: | 2.72 |
Quick Ratio: | 2.05 |
Price-to-Earnings
Trailing P/E Ratio: | 22.84 |
---|---|
Forward P/E Ratio: | 16.7 |
AYI Technical Analysis vs Fundamental Analysis
Buy
73
Acuity Brands (AYI)
is a Buy
Is Acuity Brands a Buy or a Sell?
-
Acuity Brands stock is rated a Buy
The current Acuity Brands [AYI] share price is $307.00. The Score for AYI is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.